APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

OTC Cold and Cough Medicines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Cold and Cough Medicines Market Outlook and Growth Opportunities 2026

Report ID 174021000431 December 2025195 pages

Choose your research edition.

Industry ResearchOTC Cold and Cough Medicines Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Cold and Cough Medicines Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal OTC Cold and Cough Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Cold and Cough Medicines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Cold and Cough Medicines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global OTC Cold and Cough Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Cold and Cough Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Cold and Cough Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Cold and Cough Medicines market include Sun Pharmaceutical, Johnson & Johnson, Novartis AG, Pfizer Inc., GlaxoSmithKline Plc., Sanofi-Aventis, Reckitt Benckiser Group Plc., Procter & Gamble Co. and Prestige Brands Holdings, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Cold and Cough Medicines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Cold and Cough Medicines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Cold and Cough Medicines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Cold and Cough Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Cold and Cough Medicines Segment by Company

Sun Pharmaceutical

Johnson & Johnson

Novartis AG

Pfizer Inc.

GlaxoSmithKline Plc.

Sanofi-Aventis

Reckitt Benckiser Group Plc.

Procter & Gamble Co.

Prestige Brands Holdings, Inc.

AstraZeneca Plc.

OTC Cold and Cough Medicines Segment by Type

Drops

Powders

Capsules

Sprays

Tablets

Pellets

OTC Cold and Cough Medicines Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

OTC Cold and Cough Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Cold and Cough Medicines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions OTC Cold and Cough Medicines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Cold and Cough Medicines significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Cold and Cough Medicines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Cold and Cough Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Cold and Cough Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Cold and Cough Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Cold and Cough Medicines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Cold and Cough Medicines industry.

Chapter 3: Detailed analysis of OTC Cold and Cough Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of OTC Cold and Cough Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of OTC Cold and Cough Medicines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Cold and Cough Medicines Industry Trends Table 2. OTC Cold and Cough Medicines Industry Drivers Table 3. OTC Cold and Cough Medicines Industry Opportunities and Challenges Table 4. OTC Cold and Cough Medicines Industry Restraints Table 5. Global OTC Cold and Cough Medicines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Cold and Cough Medicines Revenue Share by Company (2021-2026) Table 7. Global OTC Cold and Cough Medicines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global OTC Cold and Cough Medicines Sales Volume Share by Company (2021-2026) Table 9. Global OTC Cold and Cough Medicines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global OTC Cold and Cough Medicines Company Ranking, (2024-2026) & (USD Million) Table 11. Global OTC Cold and Cough Medicines Key Company Manufacturing Base & Headquarters Table 12. Global OTC Cold and Cough Medicines Company, Product Type & Application Table 13. Global OTC Cold and Cough Medicines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Cold and Cough Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Drops Table 18. Significant Companies of Powders Table 19. Significant Companies of Capsules Table 20. Significant Companies of Sprays Table 21. Significant Companies of Tablets Table 22. Significant Companies of Pellets Table 23. Global OTC Cold and Cough Medicines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global OTC Cold and Cough Medicines Sales Volume by Type (2021-2026) & (K Units) Table 25. Global OTC Cold and Cough Medicines Sales Volume by Type (2027-2032) & (K Units) Table 26. Global OTC Cold and Cough Medicines Sales Volume Share by Type (2021-2026) Table 27. Global OTC Cold and Cough Medicines Sales Volume Share by Type (2027-2032) Table 28. Global OTC Cold and Cough Medicines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global OTC Cold and Cough Medicines Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global OTC Cold and Cough Medicines Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global OTC Cold and Cough Medicines Sales Value Share by Type (2021-2026) Table 32. Global OTC Cold and Cough Medicines Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hospital Pharmacies Table 34. Significant Companies of Online Pharmacies Table 35. Significant Companies of Retail Pharmacies Table 36. Global OTC Cold and Cough Medicines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global OTC Cold and Cough Medicines Sales Volume by Application (2021-2026) & (K Units) Table 38. Global OTC Cold and Cough Medicines Sales Volume by Application (2027-2032) & (K Units) Table 39. Global OTC Cold and Cough Medicines Sales Volume Share by Application (2021-2026) Table 40. Global OTC Cold and Cough Medicines Sales Volume Share by Application (2027-2032) Table 41. Global OTC Cold and Cough Medicines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global OTC Cold and Cough Medicines Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global OTC Cold and Cough Medicines Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global OTC Cold and Cough Medicines Sales Value Share by Application (2021-2026) Table 45. Global OTC Cold and Cough Medicines Sales Value Share by Application (2027-2032) Table 46. Global OTC Cold and Cough Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global OTC Cold and Cough Medicines Sales by Region (2021-2026) & (K Units) Table 48. Global OTC Cold and Cough Medicines Sales Market Share by Region (2021-2026) Table 49. Global OTC Cold and Cough Medicines Sales by Region (2027-2032) & (K Units) Table 50. Global OTC Cold and Cough Medicines Sales Market Share by Region (2027-2032) Table 51. Global OTC Cold and Cough Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global OTC Cold and Cough Medicines Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global OTC Cold and Cough Medicines Sales Value Share by Region (2021-2026) Table 54. Global OTC Cold and Cough Medicines Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global OTC Cold and Cough Medicines Sales Value Share by Region (2027-2032) Table 56. Global OTC Cold and Cough Medicines Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global OTC Cold and Cough Medicines Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global OTC Cold and Cough Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global OTC Cold and Cough Medicines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global OTC Cold and Cough Medicines Sales by Country (2021-2026) & (K Units) Table 61. Global OTC Cold and Cough Medicines Sales Market Share by Country (2021-2026) Table 62. Global OTC Cold and Cough Medicines Sales by Country (2027-2032) & (K Units) Table 63. Global OTC Cold and Cough Medicines Sales Market Share by Country (2027-2032) Table 64. Global OTC Cold and Cough Medicines Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global OTC Cold and Cough Medicines Sales Value Market Share by Country (2021-2026) Table 66. Global OTC Cold and Cough Medicines Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global OTC Cold and Cough Medicines Sales Value Market Share by Country (2027-2032) Table 68. Sun Pharmaceutical Company Information Table 69. Sun Pharmaceutical Business Overview Table 70. Sun Pharmaceutical OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolio Table 72. Sun Pharmaceutical Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson OTC Cold and Cough Medicines Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Novartis AG Company Information Table 79. Novartis AG Business Overview Table 80. Novartis AG OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis AG OTC Cold and Cough Medicines Product Portfolio Table 82. Novartis AG Recent Development Table 83. Pfizer Inc. Company Information Table 84. Pfizer Inc. Business Overview Table 85. Pfizer Inc. OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Inc. OTC Cold and Cough Medicines Product Portfolio Table 87. Pfizer Inc. Recent Development Table 88. GlaxoSmithKline Plc. Company Information Table 89. GlaxoSmithKline Plc. Business Overview Table 90. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolio Table 92. GlaxoSmithKline Plc. Recent Development Table 93. Sanofi-Aventis Company Information Table 94. Sanofi-Aventis Business Overview Table 95. Sanofi-Aventis OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolio Table 97. Sanofi-Aventis Recent Development Table 98. Reckitt Benckiser Group Plc. Company Information Table 99. Reckitt Benckiser Group Plc. Business Overview Table 100. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolio Table 102. Reckitt Benckiser Group Plc. Recent Development Table 103. Procter & Gamble Co. Company Information Table 104. Procter & Gamble Co. Business Overview Table 105. Procter & Gamble Co. OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolio Table 107. Procter & Gamble Co. Recent Development Table 108. Prestige Brands Holdings, Inc. Company Information Table 109. Prestige Brands Holdings, Inc. Business Overview Table 110. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolio Table 112. Prestige Brands Holdings, Inc. Recent Development Table 113. AstraZeneca Plc. Company Information Table 114. AstraZeneca Plc. Business Overview Table 115. AstraZeneca Plc. OTC Cold and Cough Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolio Table 117. AstraZeneca Plc. Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. OTC Cold and Cough Medicines Distributors List Table 121. OTC Cold and Cough Medicines Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. OTC Cold and Cough Medicines Product Image Figure 2. Global OTC Cold and Cough Medicines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Cold and Cough Medicines Sales Value (2021-2032) & (US$ Million) Figure 4. Global OTC Cold and Cough Medicines Sales (2021-2032) & (K Units) Figure 5. Global OTC Cold and Cough Medicines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global OTC Cold and Cough Medicines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Drops Image Figure 10. Powders Image Figure 11. Capsules Image Figure 12. Sprays Image Figure 13. Tablets Image Figure 14. Pellets Image Figure 15. Global OTC Cold and Cough Medicines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global OTC Cold and Cough Medicines Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global OTC Cold and Cough Medicines Sales Volume Share by Type (2021-2032) Figure 18. Global OTC Cold and Cough Medicines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global OTC Cold and Cough Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global OTC Cold and Cough Medicines Sales Value Share by Type (2021-2032) Figure 21. Hospital Pharmacies Image Figure 22. Online Pharmacies Image Figure 23. Retail Pharmacies Image Figure 24. Global OTC Cold and Cough Medicines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global OTC Cold and Cough Medicines Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global OTC Cold and Cough Medicines Sales Volume Share by Application (2021-2032) Figure 27. Global OTC Cold and Cough Medicines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global OTC Cold and Cough Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global OTC Cold and Cough Medicines Sales Value Share by Application (2021-2032) Figure 30. Global OTC Cold and Cough Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global OTC Cold and Cough Medicines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global OTC Cold and Cough Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global OTC Cold and Cough Medicines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America OTC Cold and Cough Medicines Sales Value (2021-2032) & (US$ Million) Figure 35. North America OTC Cold and Cough Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe OTC Cold and Cough Medicines Sales Value (2021-2032) & (US$ Million) Figure 37. Europe OTC Cold and Cough Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific OTC Cold and Cough Medicines Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific OTC Cold and Cough Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America OTC Cold and Cough Medicines Sales Value (2021-2032) & (US$ Million) Figure 41. South America OTC Cold and Cough Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa OTC Cold and Cough Medicines Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa OTC Cold and Cough Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. OTC Cold and Cough Medicines Value Chain Figure 129. Manufacturing Cost Structure Figure 130. OTC Cold and Cough Medicines Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Drops
  • Powders
  • Capsules
  • Sprays
  • Tablets
  • Pellets
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline Plc.
  • Sanofi-Aventis
  • Reckitt Benckiser Group Plc.
  • Procter & Gamble Co.
  • Prestige Brands Holdings, Inc.
  • AstraZeneca Plc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global OTC Cold and Cough Medicines Sales Value (2021-2032)
  4. 1.2.2 Global OTC Cold and Cough Medicines Sales Volume (2021-2032)
  5. 1.2.3 Global OTC Cold and Cough Medicines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 OTC Cold and Cough Medicines Market Dynamics
  1. 2.1 OTC Cold and Cough Medicines Industry Trends
  2. 2.2 OTC Cold and Cough Medicines Industry Drivers
  3. 2.3 OTC Cold and Cough Medicines Industry Opportunities and Challenges
  4. 2.4 OTC Cold and Cough Medicines Industry Restraints
3 OTC Cold and Cough Medicines Market by Company
  1. 3.1 Global OTC Cold and Cough Medicines Company Revenue Ranking in 2025
  2. 3.2 Global OTC Cold and Cough Medicines Revenue by Company (2021-2026)
  3. 3.3 Global OTC Cold and Cough Medicines Sales Volume by Company (2021-2026)
  4. 3.4 Global OTC Cold and Cough Medicines Average Price by Company (2021-2026)
  5. 3.5 Global OTC Cold and Cough Medicines Company Ranking (2024-2026)
  6. 3.6 Global OTC Cold and Cough Medicines Company Manufacturing Base and Headquarters
  7. 3.7 Global OTC Cold and Cough Medicines Company Product Type and Application
  8. 3.8 Global OTC Cold and Cough Medicines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global OTC Cold and Cough Medicines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 OTC Cold and Cough Medicines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 OTC Cold and Cough Medicines Market by Type
  1. 4.1 OTC Cold and Cough Medicines Type Introduction
  2. 4.1.1 Drops
  3. 4.1.2 Powders
  4. 4.1.3 Capsules
  5. 4.1.4 Sprays
  6. 4.1.5 Tablets
  7. 4.1.6 Pellets
  8. 4.2 Global OTC Cold and Cough Medicines Sales Volume by Type
  9. 4.2.1 Global OTC Cold and Cough Medicines Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global OTC Cold and Cough Medicines Sales Volume by Type (2021-2032)
  11. 4.2.3 Global OTC Cold and Cough Medicines Sales Volume Share by Type (2021-2032)
  12. 4.3 Global OTC Cold and Cough Medicines Sales Value by Type
  13. 4.3.1 Global OTC Cold and Cough Medicines Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global OTC Cold and Cough Medicines Sales Value by Type (2021-2032)
  15. 4.3.3 Global OTC Cold and Cough Medicines Sales Value Share by Type (2021-2032)
5 OTC Cold and Cough Medicines Market by Application
  1. 5.1 OTC Cold and Cough Medicines Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global OTC Cold and Cough Medicines Sales Volume by Application
  6. 5.2.1 Global OTC Cold and Cough Medicines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Cold and Cough Medicines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global OTC Cold and Cough Medicines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global OTC Cold and Cough Medicines Sales Value by Application
  10. 5.3.1 Global OTC Cold and Cough Medicines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global OTC Cold and Cough Medicines Sales Value by Application (2021-2032)
  12. 5.3.3 Global OTC Cold and Cough Medicines Sales Value Share by Application (2021-2032)
6 OTC Cold and Cough Medicines Regional Sales and Value Analysis
  1. 6.1 Global OTC Cold and Cough Medicines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Cold and Cough Medicines Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Cold and Cough Medicines Sales by Region: 2021-2026
  4. 6.2.2 Global OTC Cold and Cough Medicines Sales by Region (2027-2032)
  5. 6.3 Global OTC Cold and Cough Medicines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global OTC Cold and Cough Medicines Sales Value by Region (2021-2032)
  7. 6.4.1 Global OTC Cold and Cough Medicines Sales Value by Region: 2021-2026
  8. 6.4.2 Global OTC Cold and Cough Medicines Sales Value by Region (2027-2032)
  9. 6.5 Global OTC Cold and Cough Medicines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America OTC Cold and Cough Medicines Sales Value (2021-2032)
  12. 6.6.2 North America OTC Cold and Cough Medicines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe OTC Cold and Cough Medicines Sales Value (2021-2032)
  15. 6.7.2 Europe OTC Cold and Cough Medicines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific OTC Cold and Cough Medicines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific OTC Cold and Cough Medicines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America OTC Cold and Cough Medicines Sales Value (2021-2032)
  21. 6.9.2 South America OTC Cold and Cough Medicines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa OTC Cold and Cough Medicines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa OTC Cold and Cough Medicines Sales Value Share by Country, 2025 VS 2032
7 OTC Cold and Cough Medicines Country-level Sales and Value Analysis
  1. 7.1 Global OTC Cold and Cough Medicines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Cold and Cough Medicines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global OTC Cold and Cough Medicines Sales by Country (2021-2032)
  4. 7.3.1 Global OTC Cold and Cough Medicines Sales by Country (2021-2026)
  5. 7.3.2 Global OTC Cold and Cough Medicines Sales by Country (2027-2032)
  6. 7.4 Global OTC Cold and Cough Medicines Sales Value by Country (2021-2032)
  7. 7.4.1 Global OTC Cold and Cough Medicines Sales Value by Country (2021-2026)
  8. 7.4.2 Global OTC Cold and Cough Medicines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt OTC Cold and Cough Medicines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt OTC Cold and Cough Medicines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt OTC Cold and Cough Medicines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical OTC Cold and Cough Medicines Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson OTC Cold and Cough Medicines Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis AG
  14. 8.3.1 Novartis AG Company Information
  15. 8.3.2 Novartis AG Business Overview
  16. 8.3.3 Novartis AG OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis AG OTC Cold and Cough Medicines Product Portfolio
  18. 8.3.5 Novartis AG Recent Developments
  19. 8.4 Pfizer Inc.
  20. 8.4.1 Pfizer Inc. Company Information
  21. 8.4.2 Pfizer Inc. Business Overview
  22. 8.4.3 Pfizer Inc. OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc. OTC Cold and Cough Medicines Product Portfolio
  24. 8.4.5 Pfizer Inc. Recent Developments
  25. 8.5 GlaxoSmithKline Plc.
  26. 8.5.1 GlaxoSmithKline Plc. Company Information
  27. 8.5.2 GlaxoSmithKline Plc. Business Overview
  28. 8.5.3 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Plc. OTC Cold and Cough Medicines Product Portfolio
  30. 8.5.5 GlaxoSmithKline Plc. Recent Developments
  31. 8.6 Sanofi-Aventis
  32. 8.6.1 Sanofi-Aventis Company Information
  33. 8.6.2 Sanofi-Aventis Business Overview
  34. 8.6.3 Sanofi-Aventis OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi-Aventis OTC Cold and Cough Medicines Product Portfolio
  36. 8.6.5 Sanofi-Aventis Recent Developments
  37. 8.7 Reckitt Benckiser Group Plc.
  38. 8.7.1 Reckitt Benckiser Group Plc. Company Information
  39. 8.7.2 Reckitt Benckiser Group Plc. Business Overview
  40. 8.7.3 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Reckitt Benckiser Group Plc. OTC Cold and Cough Medicines Product Portfolio
  42. 8.7.5 Reckitt Benckiser Group Plc. Recent Developments
  43. 8.8 Procter & Gamble Co.
  44. 8.8.1 Procter & Gamble Co. Company Information
  45. 8.8.2 Procter & Gamble Co. Business Overview
  46. 8.8.3 Procter & Gamble Co. OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Procter & Gamble Co. OTC Cold and Cough Medicines Product Portfolio
  48. 8.8.5 Procter & Gamble Co. Recent Developments
  49. 8.9 Prestige Brands Holdings, Inc.
  50. 8.9.1 Prestige Brands Holdings, Inc. Company Information
  51. 8.9.2 Prestige Brands Holdings, Inc. Business Overview
  52. 8.9.3 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Prestige Brands Holdings, Inc. OTC Cold and Cough Medicines Product Portfolio
  54. 8.9.5 Prestige Brands Holdings, Inc. Recent Developments
  55. 8.10 AstraZeneca Plc.
  56. 8.10.1 AstraZeneca Plc. Company Information
  57. 8.10.2 AstraZeneca Plc. Business Overview
  58. 8.10.3 AstraZeneca Plc. OTC Cold and Cough Medicines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Plc. OTC Cold and Cough Medicines Product Portfolio
  60. 8.10.5 AstraZeneca Plc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Cold and Cough Medicines Value Chain Analysis
  2. 9.1.1 OTC Cold and Cough Medicines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Cold and Cough Medicines Sales Mode & Process
  6. 9.2 OTC Cold and Cough Medicines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Cold and Cough Medicines Distributors
  9. 9.2.3 OTC Cold and Cough Medicines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst